ISSM/SLAMS Webinar on Testosterone, Sexual Medicine and Prostate Cancer

Our aim is to assess the effects of testosterone replacement therapy (TRT) on male health indicators in hypogonadal men, and the impact on sexual quality of life and prostate cancer risk. Testosterone prescriptions have nearly tripled in recent years; however, it is clear from clinical practice that there are many men using testosterone without a clear indication and others who need TRT who do not receive it due to clinical concerns, particularly around the development of prostate cancer and cardiovascular events. Therefore, the ISSM identified the need to produce an evidence-based webinar that informs how we can treat men effectively and safely.

Program
Opening by SLAMS and ISSM Representatives
Welcome by moderator: Leonardo Seligra Lopes (Brazil)
Testosterone in Prostate Cancer: Landon Trost (USA)
Testosterone and Sexual Function: Sidney Glina (Brazil)
Live roundtables discussion with panallists: Mohit Khera (USA), Juan Andino (USA), and Edwin Reyes (Brazil).